Annual Net Income
-$24.22 M
+$3.42 M+12.39%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual net profit is -$24.22 million, with the most recent change of +$3.42 million (+12.39%) on December 31, 2023.
- During the last 3 years, CMMB annual net income has fallen by -$18.27 million (-307.01%).
- CMMB annual net income is now -307.01% below its all-time high of -$5.95 million, reached on December 31, 2020.
Performance
CMMB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$3.48 M
+$148.00 K+4.08%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly net profit is -$3.48 million, with the most recent change of +$148.00 thousand (+4.08%) on September 1, 2024.
- Over the past year, CMMB quarterly net income has increased by +$148.00 thousand (+4.08%).
- CMMB quarterly net income is now -222.20% below its all-time high of -$1.08 million, reached on June 30, 2020.
Performance
CMMB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$14.40 M
+$598.00 K+3.99%
September 1, 2024
Summary
- As of February 8, 2025, CMMB TTM net profit is -$14.40 million, with the most recent change of +$598.00 thousand (+3.99%) on September 1, 2024.
- Over the past year, CMMB TTM net income has increased by +$598.00 thousand (+3.99%).
- CMMB TTM net income is now -749.50% below its all-time high of -$1.70 million, reached on March 31, 2020.
Performance
CMMB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CMMB Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | +4.1% | +4.0% |
| 3 y3 years | -307.0% | +4.1% | +4.0% |
| 5 y5 years | -307.0% | +4.1% | +4.0% |
CMMB Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.1% | +12.4% | -1.9% | +60.2% | -15.4% | +56.5% |
| 5 y | 5-year | -307.0% | +12.4% | -222.2% | +60.2% | -749.5% | +56.5% |
| alltime | all time | -307.0% | +12.4% | -222.2% | +60.2% | -749.5% | +56.5% |
Chemomab Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.48 M(-4.1%) | -$14.40 M(-4.0%) |
| Jun 2024 | - | -$3.63 M(-6.1%) | -$15.00 M(-22.4%) |
| Mar 2024 | - | -$3.87 M(+13.2%) | -$19.34 M(-20.2%) |
| Dec 2023 | -$24.22 M(-12.4%) | -$3.42 M(-16.3%) | -$24.22 M(-16.7%) |
| Sep 2023 | - | -$4.08 M(-48.8%) | -$29.08 M(-12.1%) |
| Jun 2023 | - | -$7.97 M(-8.9%) | -$33.08 M(+5.7%) |
| Mar 2023 | - | -$8.75 M(+5.8%) | -$31.30 M(+13.2%) |
| Dec 2022 | -$27.65 M | -$8.27 M(+2.4%) | -$27.65 M(+13.3%) |
| Sep 2022 | - | -$8.08 M(+30.5%) | -$24.41 M(+26.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.19 M(+21.3%) | -$19.30 M(+21.5%) |
| Mar 2022 | - | -$5.10 M(+1.4%) | -$15.88 M(+27.2%) |
| Dec 2021 | -$12.48 M(+109.7%) | -$5.04 M(+69.7%) | -$12.48 M(+32.8%) |
| Sep 2021 | - | -$2.97 M(+7.1%) | -$9.39 M(+22.8%) |
| Jun 2021 | - | -$2.77 M(+62.6%) | -$7.65 M(+28.3%) |
| Mar 2021 | - | -$1.70 M(-12.7%) | -$5.96 M(+0.2%) |
| Dec 2020 | -$5.95 M | -$1.95 M(+59.4%) | -$5.95 M(+48.8%) |
| Sep 2020 | - | -$1.22 M(+13.2%) | -$4.00 M(+44.1%) |
| Jun 2020 | - | -$1.08 M(-36.2%) | -$2.78 M(+63.8%) |
| Mar 2020 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Chemomab Therapeutics annual net profit?
- What is the all time high annual net income for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual net income year-on-year change?
- What is Chemomab Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly net income year-on-year change?
- What is Chemomab Therapeutics TTM net profit?
- What is the all time high TTM net income for Chemomab Therapeutics?
- What is Chemomab Therapeutics TTM net income year-on-year change?
What is Chemomab Therapeutics annual net profit?
The current annual net income of CMMB is -$24.22 M
What is the all time high annual net income for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual net profit is -$5.95 M
What is Chemomab Therapeutics annual net income year-on-year change?
Over the past year, CMMB annual net profit has changed by +$3.42 M (+12.39%)
What is Chemomab Therapeutics quarterly net profit?
The current quarterly net income of CMMB is -$3.48 M
What is the all time high quarterly net income for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly net profit is -$1.08 M
What is Chemomab Therapeutics quarterly net income year-on-year change?
Over the past year, CMMB quarterly net profit has changed by +$148.00 K (+4.08%)
What is Chemomab Therapeutics TTM net profit?
The current TTM net income of CMMB is -$14.40 M
What is the all time high TTM net income for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM net profit is -$1.70 M
What is Chemomab Therapeutics TTM net income year-on-year change?
Over the past year, CMMB TTM net profit has changed by +$598.00 K (+3.99%)